Jul 1, 06:15 PM

FTC Opens Civil Investigation into Teva Pharmaceuticals Over Asthma and COPD Drug Patents

The US Federal Trade Commission (FTC) has opened a civil investigation into Teva Pharmaceutical Industries Ltd. over its patents for certain drugs, including asthma and COPD inhalers. The investigation focuses on what the FTC describes as 'junk patent listings' and involves about two dozen patents that Teva has refused to remove from a key federal registry. These patents are allegedly improperly listed in an FDA database. The FTC's probe has already impacted Teva's stock, which fell following the news.

#US Federal Trade Commission #FTC #Teva #FDA

Written with ChatGPT (GPT-4o).